New human clinical study demonstrates the efficacy and value of Phynova’s Reducose® as a functional ingredient to promote healthy blood sugar

Phynova is pleased to announce that its natural plant-based functional ingredient, Reducose®, has further demonstrated its effectiveness at maintaining healthy blood glucose levels in a clinical trial run in conjunction with researchers from Oxford Brookes Centre for Nutrition and Health, Oxford Brookes University. The trial was a randomized, double-blind, placebo-controlled study in healthy individuals that investigated the effectiveness of a small dose of 250mg of Reducose® on lowering blood glucose and blood insulin responses after the ingestion of sugar (sucrose). This latest published study complements the four other completed trials with Reducose (a sixth study is ongoing), that showed that Reducose® is effective with a wide range of carbohydrates.

The study demonstrated that Reducose® significantly suppressed -by more than 40%- total blood glucose and insulin rises after ingestion of sugar in healthy adults, which can help consumers to maintain healthy blood glucose and insulin levels. This finding improved on the reduction in postprandial glucose levels from previous published research and demonstrated that optimizing how Reducose® is used is important for gaining maximum benefit. The study reported that Reducose® is well tolerated and there were no adverse events recorded.

Stephane Ducroux, CEO at Phynova, said: 'I am extremely excited with the positive results of this new clinical trial that confirms again the benefits of Reducose® for helping people maintain healthy blood glucose levels. The results from this study shows that Reducose is one of the most effective functional ingredients out there for lowering blood glucose rises after eating, but it delivers this benefit in a dose that is considerably smaller than most other ingredients, offering a compelling cost-in-use and giving our customers a range of options for creating bespoke formulations'. Andrew Gallagher, Phynova's lead scientist in the study added 'The results of this study again confirmed the clinical benefits for consumers in using Reducose®. Excess carbohydrates in our diet can negatively impact our metabolic health and by lowering the amount of glucose that gets into the body, the benefits of using Reducose® may extend beyond just maintaining healthy blood glucose levels. Recently published data has shown that poorly controlled blood glucose levels can increase risk of complications from Covid-19 and so there has never been a more important time for people to look after themselves and eat healthily.'

The findings of the study are now published in 'Nutrition & Metabolism', a well-established journal that publishes studies focused on nutrition and metabolism with an emphasis on obesity, diabetes, lipidemia, metabolic syndrome and exercise physiology. https://rdcu.be/ciMa8